Why Teva Pharmaceutical Is Getting Hammered Today

FAN Editor

What happened

Share of Israeli generic-drug giant Teva Pharmaceutical Industries (NYSE: TEVA) fell by an eye-popping 16.5% as of 12:56 p.m EDT today. What’s causing this double-digit dip?

Continue Reading Below

Teva’s stock is cratering in response to the news that a whopping 44 U.S. states have filed an antitrust lawsuit against the company, as well as several other top pharma entities, over an alleged industrywide price-fixing scheme that occurred mainly from July 2013 to January 2015. Over the weekend, Teva denied any wrongdoing.

So what

Although Teva is far from the only household name to pop up in this lengthy court filing, the company is cast as the main culprit behind the conspiracy. That puts Teva in line to possibly receive a massive fine that could come in at around $2 billion, according to pharma analyst Steven Tepper.

Given Teva’s poor financial health and anemic growth prospects, it can ill afford a fine of that magnitude. Fortunately, these types of lawsuits often take several years to work their way through the courts, giving the company some much-needed time to assess its options and form a legal strategy.

Now what

If you’re thinking about buying Teva on this hefty pullback, you might want to think again. Teva’s debt-to-equity ratio is among the highest in the healthcare sector, and sales of the company’s flagship multiple sclerosis medication, Copaxone, haven’t hit rock bottom quite yet. The company does have some promising new growth products like Austedo and Ajovy under its umbrella, but these two drugs simply aren’t enough to change the company’s underlying fundamentals — at least not anytime soon. For the moment, you may want to avoid this falling knife.

10 stocks we like better than Teva Pharmaceutical IndustriesWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now… and Teva Pharmaceutical Industries wasn’t one of them! That’s right — they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of March 1, 2019

George Budwell has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Free America Network Articles

Leave a Reply

Next Post

Conservative Supreme Court justices spar over executions of Muslim, Buddhist inmates

Why did Justice Brett Kavanaugh oppose a stay of execution for a Muslim inmate denied an imam in the death chamber but support a stay for a Buddhist inmate denied a Buddhist priest by his side? In a highly unusual move, more than a month after the decision came down, […]